Johnson & Johnson (J&J) is an American multinational corporation focusing on pharmaceuticals, biotechnology, and medical technologies. Founded in New Brunswick, New Jersey in 1886 by brothers Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, it initially produced ready-to-use sterile surgical dressings. Over time, J&J developed well-known healthcare products such as the first commercial first aid kit, baby powder, and Band-Aids. The company is publicly traded on the New York Stock Exchange and its common stock is a component of the Dow Jones Industrial Average.
J&J is structured into two business segments: Innovative Medicine and MedTech. The Innovative Medicine segment focuses on pharmaceuticals for immunology, oncology, neuroscience, cardiopulmonary, and specialty ophthalmology. The MedTech segment focuses on medical devices and treatments in areas like cardiovascular health, orthopedics, surgery, and vision. Key people include Joaquin Duato, who serves as Chairman and CEO. In his third year as CEO, Duato's overall compensation package was valued at $24.3 million. Recent news includes a potential sale of its DePuy Synthes orthopedics unit, and a $1 billion investment in a Pennsylvania manufacturing facility. As of February 2026, Johnson & Johnson has a market capitalization of €496.53 billion.